The roles of biomarkers of oxidative stress and antioxidant in alzheimer's disease: A systematic review

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Chang, Ya Ting ^a,b   Chang, Wen Neng ^a   Tsai, Nai Wen ^a   Huang, Chih Cheng ^a   Kung, Chia Te ^a   Su, Yu Jih ^a,b   Lin, Wei Che ^a   Cheng, Ben Chung ^a,b   Su, Chih Min ^a,b   Chiang, Yi Fang ^a   Lu, Cheng Hsien ^a,b  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYNONENAL; ALKADIENE; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BIOLOGICAL MARKER; CARBONYL DERIVATIVE; CAROTENOID; DNA; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HYDROPEROXIDE; MALONALDEHYDE; OXIDIZED LOW DENSITY LIPOPROTEIN; PHOSPHOLIPID; PLASMA PROTEIN; RETINOL; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; URIC ACID;

ALZHEIMER DISEASE; BLOOD LEVEL; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID LEVEL; COGNITIVE DEFECT; DISEASE SEVERITY; ERYTHROCYTE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIPID PEROXIDATION; META ANALYSIS (TOPIC); OUTCOME ASSESSMENT; OXIDATION; OXIDATIVE STRESS; PREDICTOR VARIABLE; PROTEIN CARBONYLATION; REVIEW; SYSTEMATIC REVIEW; ANIMAL; BLOOD; MEDLINE; METABOLISM;

ALZHEIMER DISEASE; ANIMALS; ANTIOXIDANTS; BIOLOGICAL MARKERS; HUMANS; LIPID PEROXIDATION; OXIDATIVE STRESS; PUBMED;

EID: 84901779460     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/182303     Document Type: Review

References (76)

1. Weiner M. W., Veitch D. P., Aisen P. S., Beckett L. A., Cairns N. J., Green R. C., Harvey D., Jack C. R., Jagust W., Liu E., Morris J. C., Petersen R. C., Saykin A. J., Schmidt M. E., Shaw L., Siuciak J. A., Soares H., Toga A. W., Trojanowski J. Q., The Alzheimer's disease neuroimaging initiative: a review of papers published since its inception. Alzheimer's and Dementia 2012 8 1, supplement S1 S68 2-s2.0-84856414697 10.1016/j.jalz.2011.09.172
2. Hardy J. A., Higgins G. A., Alzheimer's disease: the amyloid cascade hypothesis. Science 1992 256 5054 184 185 2-s2.0-0026597063
3. Smith M. A., Rottkamp C. A., Nunomura A., Raina A. K., Perry G., Oxidative stress in Alzheimer's disease. Biochimica et Biophysica Acta 2000 1502 1 139 144 (Pubitemid 30433863)
4. Migliore L., Fontana I., Trippi F., Colognato R., Coppedè F., Tognoni G., Nucciarone B., Siciliano G., Oxidative DNA damage in peripheral leukocytes of mild cognitive impairment and AD patients. Neurobiology of Aging 2005 26 5 567 573 2-s2.0-13644270565 10.1016/j.neurobiolaging.2004.07.016 (Pubitemid 40228745)
5. Casado Á., Encarnación López-Fernández M., Concepción Casado M., De La Torre R., Lipid peroxidation and antioxidant enzyme activities in vascular and alzheimer dementias. Neurochemical Research 2008 33 3 450 458 2-s2.0-38949123654 10.1007/s11064-007-9453-3 (Pubitemid 351230446)
6. Serra J. A., Domínguez R. O., De Lustig E. S., Guareschi E. M., Famulari A. L., Bartolomé E. L., Marschoff E. R., Parkinson's disease is associated with oxidative stress: comparison of peripheral antioxidant profiles in living Parkinson's, Alzheimer's and vascular dementia patients. Journal of Neural Transmission 2001 108 10 1135 1148 2-s2.0-0034750776 10.1007/ s007020170003 (Pubitemid 33022763)
7. Cristalli D. O., Arnal N., Marra F. A., De Alaniz M. J. T., Marra C. A., Peripheral markers in neurodegenerative patients and their first-degree relatives. Journal of the Neurological Sciences 2012 314 1-2 48 56 2-s2.0-84857037658 10.1016/j.jns.2011.11.001
8. Carantoni M., Zuliani G., Munari M. R., D'Elia K., Palmieri E., Fellin R., Alzheimer disease and vascular dementia: relationships with fasting glucose and insulin levels. Dementia and Geriatric Cognitive Disorders 2000 11 3 176 180 2-s2.0-0033999608 (Pubitemid 30216211)
9. Sinclair A. J., Bayer A. J., Johnston J., Warner C., Maxwell S. R., Altered plasma antioxidant status in subjects with Alzheimer's disease and vascular dementia. International Journal of Geriatric Psychiatry 1998 13 12 840 845 (Pubitemid 28564482)
10. Foy C. J., Passmore A. P., Vahidassr M. D., Young I. S., Lawson J. T., Plasma chain-breaking antioxidants in Alzheimer's disease, vascular dementia and Parkinson's disease. QJM 1999 92 1 39 45 2-s2.0-0032921546 (Pubitemid 29034099)
11. Ihara Y., Hayabara T., Sasaki K., Fujisawa Y., Kawada R., Yamamoto T., Nakashima Y., Yoshimune S., Kawai M., Kibata M., Kuroda S., Free radicals and superoxide dismutase in blood of patients with Alzheimer's disease and vascular dementia. Journal of the Neurological Sciences 1997 153 1 76 81 2-s2.0-0031471491 10.1016/S0022-510X(97)00172-X (Pubitemid 28010070)
12. Guidi I., Galimberti D., Lonati S., Novembrino C., Bamonti F., Tiriticco M., Fenoglio C., Venturelli E., Baron P., Bresolin N., Scarpini E., Oxidative imbalance in patients with mild cognitive impairment and Alzheimer's disease. Neurobiology of Aging 2006 27 2 262 269 2-s2.0-29844435497 10.1016/j. neurobiolaging.2005.01.001 (Pubitemid 43038550)
13. Bermejo P., Gomez-Serranillos P., Santos J., Pastor E., Gil P., Martin-Aragon S., Determination of malonaldehyde in Alzheimer's disease: a comparative study of high-performance liquid chromatography and thiobarbituric acid test. Gerontology 1997 43 4 218 222 2-s2.0-0030747490 (Pubitemid 27285470)
14. Aksenov M. Y., Aksenova M. V., Butterfield D. A., Geddes J. W., Markesbery W. R., Protein oxidation in the brain in Alzheimer's disease. Neuroscience 2001 103 2 373 383 2-s2.0-0035857738 10.1016/S0306-4522(00)00580-7 (Pubitemid 32201924)
15. Bourdel-Marchasson I., Delmas-Beauviex M.-C., Peuchant E., Richard-Harston S., Decamps A., Reigneir B., Emeriau J.-P., Rainfray M., Antioxidant defences and oxidative stress markers in erythrocytes and plasma from normally nourished elderly Alzheimer patients. Age and Ageing 2001 30 3 235 241 2-s2.0-0034914927 10.1093/ageing/30.3.235 (Pubitemid 32684904)
16. Mecocci P., Cristina Polidori M., Cherubini A., Ingegni T., Mattioli P., Catani M., Rinaldi P., Cecchetti R., Stahl W., Senin U., Flint Beal M., Lymphocyte oxidative DNA damage and plasma antioxidants in Alzheimer disease. Archives of Neurology 2002 59 5 794 798 2-s2.0-0036094092 (Pubitemid 34517762)
17. Aldred S., Bennett S., Mecocci P., Increased low-density lipoprotein oxidation, but not total plasma protein oxidation, in Alzheimer's disease. Clinical Biochemistry 2010 43 3 267 271 2-s2.0-74249094452 10.1016/j. clinbiochem.2009.08.021
18. Korolainen M. A., Pirttilä T., Cerebrospinal fluid, serum and plasma protein oxidation in Alzheimer's disease. Acta Neurologica Scandinavica 2009 119 1 32 38 2-s2.0-58149102031 10.1111/j.1600-0404.2008.01057.x
19. Castegna A., Thongboonkerd V., Klein J. B., Lynn B., Markesberyl W. R., Butterfield D. A., Proteomic identification of nitrated proteins in Alzheimer's disease brain. Journal of Neurochemistry 2003 85 6 1394 1401 2-s2.0-0038472495 10.1046/j.1471-4159.2003.01786.x (Pubitemid 36702552)
20. Aybek H., Ercan F., Aslan D., Şahiner T., Determination of malondialdehyde, reduced glutathione levels and APOE4 allele frequency in late-onset Alzheimer's disease in Denizli, Turkey. Clinical Biochemistry 2007 40 3-4 172 176 2-s2.0-33846226106 10.1016/j.clinbiochem.2006.09.005 (Pubitemid 46108698)
21. Ozcankaya R., Delibas N., Malondialdehyde, superoxide dismutase, melatonin, iron, copper, and zinc blood concentrations in patients with Alzheimer disease: cross-sectional study. Croatian Medical Journal 2002 43 1 28 32 2-s2.0-0036174035 (Pubitemid 34157862)
22. Serra J. A., Domínguez R. O., Marschoff E. R., Guareschi E. M., Famulari A. L., Boveris A., Systemic oxidative stress associated with the neurological diseases of aging. Neurochemical Research 2009 34 12 2122 2132 2-s2.0-70450260781 10.1007/s11064-009-9997-5
23. Sinem F., Dildar K., Gökhan E., Melda B., Orhan Y., Filiz M., The serum protein and lipid oxidation marker levels in Alzheimer's disease and effects of cholinesterase inhibitors and antipsychotic drugs therapy. Current Alzheimer Research 2010 7 5 463 469 2-s2.0-78549239223 10.2174/ 156720510791383822
24. Torres L. L., Quaglio N. B., De Souza G. T., Garcia R. T., Dati L. M. M., Moreira W. L., De Melo Loureiro A. P., De Souza-Talarico J. N., Smid J., Porto C. S., De Campos Bottino C. M., Nitrini R., De Moraes Barros S. B., Camarini R., Marcourakis T., Peripheral oxidative stress biomarkers in mild cognitive impairment and Alzheimer's disease. Journal of Alzheimer's Disease 2011 26 1 59 68 2-s2.0-80052844164 10.3233/JAD-2011-110284
25. Polidori M. C., Mecocci P., Plasma susceptibility to free radical-induced antioxidant consumption and lipid peroxidation is increased in very old subjects with Alzheimer disease. Journal of Alzheimer's Disease 2002 4 6 517 522 2-s2.0-0036970014 (Pubitemid 36142841)
26. Padurariu M., Ciobica A., Hritcu L., Stoica B., Bild W., Stefanescu C., Changes of some oxidative stress markers in the serum of patients with mild cognitive impairment and Alzheimer's disease. Neuroscience Letters 2010 469 1 6 10 2-s2.0-72649096229 10.1016/j.neulet.2009.11.033
27. Martín-Aragón S., Bermejo-Bescós P., Benedí J., Felici E., Gil P., Ribera J. M., Villar Á. M., Metalloproteinase's activity and oxidative stress in mild cognitive impairment and Alzheimer's disease. Neurochemical Research 2009 34 2 373 378 2-s2.0-58849147059 10.1007/s11064-008-9789-3
28. Puertas M. C., Martínez-Martos J. M., Cobo M. P., Carrera M. P., Mayas M. D., Rami'rez-Expósito M. J., Plasma oxidative stress parameters in men and women with early stage Alzheimer type dementia. Experimental Gerontology 2012 47 8 625 630
29. Fernandes M. A., Proenca M. T., Nogueira A. J., Grazina M. M., Oliveira L. M., Fernandes A. I., Santiago B., Santana I., Oliveira C. R., Influence of apolipoprotein E genotype on blood redox status of Alzheimer's disease patients. International Journal of Molecular Medicine 1999 4 2 179 186 2-s2.0-0033175761
30. Galbusera C., Facheris M., Magni F., Galimberti G., Sala G., Tremolada L., Isella V., Guerini F. R., Appollonio I., Galli-Kienle M., Ferrarese C., Increased susceptibility to plasma lipid peroxidation in Alzheimer disease patients. Current Alzheimer Research 2004 1 2 103 109 2-s2.0-22144479780
31. Ceballos-Picot I., Merad-Boudia M., Nicole A., Thevenin M., Hellier G., Legrain S., Berr C., Peripheral antioxidant enzyme activities and selenium in elderly subjects and in dementia of Alzheimer's type-place of the extracellular glutathione peroxidase. Free Radical Biology and Medicine 1996 20 4 579 587 2-s2.0-0029871412 10.1016/0891-5849(95)02058-6 (Pubitemid 26097275)
32. Gironi M., Bianchi A., Russo A., Alberoni M., Ceresa L., Angelini A., Cursano C., Mariani E., Nemni R., Kullmann C., Farina E., Martinelli Boneschi F., Oxidative imbalance in different neurodegenerative diseases with memory impairment. Neurodegenerative Diseases 2011 8 3 129 137 2-s2.0-79953325097 10.1159/000319452
33. Kalman J., Dey I., Ilona S. V., Matkovics B., Brown D., Janka Z., Farkas T., Joo F., Platelet membrane fluidity and plasma malondialdehyde levels in Alzheimer's demented patients with and without family history of dementia. Biological Psychiatry 1994 35 3 190 194 2-s2.0-0028271474 10.1016/0006-3223(94) 91151-7 (Pubitemid 24078484)
34. McGrath L. T., McGleenon B. M., Brennan S., McColl D., McIlroy S., Passmore A. P., Increased oxidative stress in Alzheimer's disease as assessed with 4-hydroxynonenal but not malondialdehyde. QJM 2001 94 9 485 490 2-s2.0-0034834620 (Pubitemid 32894467)
35. Sekler M. A., Jiménez J. M., Rojo L., Pastene E., Fuentes P., Slachevsky A., Maccioni R. B., Cognitive impairment and Alzheimer's disease: links with oxidative stress and cholesterol metabolism. Neuropsychiatric Disease and Treatment 2008 4 4 715 722 2-s2.0-52649139517
36. Jeandel C., Nicolas M. B., Dubois F., Nabet-Belleville F., Penin F., Cuny G., Lipid peroxidation and free radical scavengers in Alzheimer's disease. Gerontology 1989 35 5-6 275 282 2-s2.0-0024789124 (Pubitemid 20015238)
37. Schrag M., Mueller C., Zabel M., Oxidative stress in blood in Alzheimer's disease and mild cognitive impairment: a meta-analysis. Neurobiology of Disease 2013 59 100 110
38. Uno M., Kitazato K. T., Nishi K., Itabe H., Nagahiro S., Raised plasma oxidised LDL in acute cerebral infarction. Journal of Neurology Neurosurgery and Psychiatry 2003 74 3 312 316 2-s2.0-0037370068 10.1136/jnnp.74.3.312 (Pubitemid 36259353)
39. Teunissen C. E., De Vente J., Steinbusch H. W. M., De Bruijn C., Biochemical markers related to Alzheimer's dementia in serum and cerebrospinal fluid. Neurobiology of Aging 2002 23 4 485 508 2-s2.0-0036250622 10.1016/S0197-4580(01)00328-1 (Pubitemid 34495461)
40. Cai Z.-Y., Yan Y., Yan L., Wang F.-Y., Huang H., Wang Y.-L., Zhao Y., Serum level of MMP-2, MMP-9 and Ox-LDL in Alzheimer's disease with hyperlipoidemia. Journal of Medical Colleges of PLA 2007 22 6 352 356 2-s2.0-77950193057 10.1016/S1000-1948(08)60017-9
41. Bermejo P., Martín-Aragón S., Benedí J., Susín C., Felici E., Gil P., Ribera J. M., Villar Á. M., Peripheral levels of glutathione and protein oxidation as markers in the development of Alzheimer's disease from Mild Cognitive Impairment. Free Radical Research 2008 42 2 162 170 2-s2.0-39749157595 10.1080/10715760701861373 (Pubitemid 351298365)
42. Conrad C. C., Marshall P. L., Talent J. M., Malakowsky C. A., Choi J., Gracy R. W., Oxidized proteins in Alzheimer's plasma. Biochemical and Biophysical Research Communications 2000 275 2 678 681
43. Sultana R., Poon H. F., Cai J., Pierce W. M., Merchant M., Klein J. B., Markesbery W. R., Butterfield D. A., Identification of nitrated proteins in Alzheimer's disease brain using a redox proteomics approach. Neurobiology of Disease 2006 22 1 76 87 2-s2.0-33645089917 10.1016/j.nbd.2005.10.004
44. Choi J., Malakowsky C. A., Talent J. M., Conrad C. C., Gracy R. W., Identification of oxidized plasma proteins in Alzheimer's disease. Biochemical and Biophysical Research Communications 2002 293 5 1566 1570 (Pubitemid 34681057)
45. Korolainen M. A., Nyman T. A., Nyyssönen P., Hartikainen E. S., Pirttilä T., Multiplexed proteomic analysis of oxidation and concentrations of cerebrospinal fluid proteins in Alzheimer disease. Clinical Chemistry 2007 53 4 657 665 2-s2.0-34147221048 10.1373/clinchem.2006.078014 (Pubitemid 46580235)
46. Ahmed N., Ahmed U., Thornalley P. J., Hager K., Fleischer G., Münch G., Protein glycation, oxidation and nitration adduct residues and free adducts of cerebrospinal fluid in Alzheimer's disease and link to cognitive impairment. Journal of Neurochemistry 2005 92 2 255 263 2-s2.0-13244270042 10.1111/j.1471-4159.2004.02864.x (Pubitemid 40194017)
47. Castegna A., Aksenov M., Aksenova M., Thongboonkerd V., Klein J. B., Pierce W. M., Booze R., Markesbery W. R., Butterfield D. A., Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1. Free Radical Biology and Medicine 2002 33 4 562 571 2-s2.0-0037101889 10.1016/S0891-5849(02)00914-0 (Pubitemid 34874977)
48. Tohgi H., Abe T., Yamazaki K., Murata T., Ishizaki E., Isobe C., Alterations of 3-nitrotyrosine concentration in the cerebrospinal fluid during aging and in patients with Alzheimer's disease. Neuroscience Letters 1999 269 1 52 54 2-s2.0-0033516677 10.1016/S0304-3940(99)00406-1 (Pubitemid 29305700)
49. Hensley K., Maidt M. L., Yu Z., Sang H., Markesbery W. R., Floyd R. A., Electrochemical analysis of protein nitrotyrosine and dityrosine in the Alzheimer brain indicates region-specific accumulation. Journal of Neuroscience 1998 18 20 8126 8132 2-s2.0-0032531735 (Pubitemid 28464991)
50. Ryberg H., Söderling A.-S., Davidsson P., Blennow K., Caidahl K., Persson L. I., Cerebrospinal fluid levels of free 3-nitrotyrosine are not elevated in the majority of patients with amyotrophic lateral sclerosis or Alzheimer's disease. Neurochemistry International 2004 45 1 57 62 2-s2.0-1842788079 10.1016/j.neuint.2003.12.012 (Pubitemid 38479564)
51. Polidori M. C., Stahl W., Eichler O., Niestroj I., Sies H., Profiles of antioxidants in human plasma. Free Radical Biology and Medicine 2001 30 5 456 462 2-s2.0-0035282571 10.1016/S0891-5849(00)00345-2 (Pubitemid 32162953)
52. Kim T.-S., Pae C.-U., Yoon S.-J., Jang W.-Y., Lee N. J., Kim J.-J., Lee S.-J., Lee C., Paik I.-H., Lee C.-U., Decreased plasma antioxidants in patients with Alzheimer's disease. International Journal of Geriatric Psychiatry 2006 21 4 344 348 2-s2.0-33646203803 10.1002/gps.1469
53. Maesaka J. K., Wolf-Klein G., Piccione J. M., Ma C. M., Hypouricemia, abnormal renal tubular urate transport, and plasma natriuretic factor(s) in patients with Alzheimer's disease. Journal of the American Geriatrics Society 1993 41 5 501 506 2-s2.0-0027155160 (Pubitemid 23135890)
54. Rinaldi P., Polidori M. C., Metastasio A., Mariani E., Mattioli P., Cherubini A., Catani M., Cecchetti R., Senin U., Mecocci P., Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer's disease. Neurobiology of Aging 2003 24 7 915 919 2-s2.0-0042591280 10.1016/S0197- 4580(03)00031-9 (Pubitemid 36962976)
55. Ruggiero C., Cherubini A., Lauretani F., Bandinelli S., Maggio M., Di Iorio A., Zuliani G., Dragonas C., Senin U., Ferrucci L., Uric acid and dementia in community-dwelling older persons. Dementia and Geriatric Cognitive Disorders 2009 27 4 382 389 2-s2.0-63349098758 10.1159/000210040
56. Schretlen D. J., Inscore A. B., Jinnah H. A., Rao V., Gordon B., Pearlson G. D., Serum uric acid and cognitive function in community-dwelling older adults. Neuropsychology 2007 21 1 136 140 2-s2.0-33846081958 10.1037/0894-4105.21.1.136 (Pubitemid 46066213)
57. Iuliano L., Monticolo R., Straface G., Spoletini I., Gianni W., Caltagirone C., Bossù P., Spalletta G., Vitamin E and enzymatic/oxidative stress-driven oxysterols in amnestic mild cognitive impairment subtypes and Alzheimer's disease. Journal of Alzheimer's Disease 2010 21 4 1383 1392 2-s2.0-78650475565 10.3233/JAD-2010-100780
58. Jiménez-Jiménez F. J., de Bustos F., Molina J. A., Cerebrospinal fluid levels of alpha-tocopherol (vitamin E) in Alzheimer's disease. Journal of Neural Transmission 1997 104 6-7 703 710 (Pubitemid 27474683)
59. Zaman Z., Roche S., Fielden P., Frost P. G., Niriella D. C., Cayley A. C. D., Plasma concentrations of vitamins A and E and carotenoids in Alzheimer's disease. Age and Ageing 1992 21 2 91 94 2-s2.0-0026547646
60. Glasø M., Nordbø G., Diep L., Bøhmer T., Reduced concentrations of several vitamins in normal weight patients with late-onset dementia of the Alzheimer type without vascular disease. Journal of Nutrition, Health and Aging 2004 8 5 407 413 2-s2.0-4644240857 (Pubitemid 39294654)
61. Sano M., Ernesto C., Thomas R. G., Klauber M. R., Schafer K., Grundman M., Woodbury P., Growdon J., Cotman C. W., Pfeiffer E., Schneider L. S., Thal L. J., A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The New England Journal of Medicine 1997 336 17 1216 1222 2-s2.0-0030967165 10.1056/NEJM199704243361704 (Pubitemid 27183651)
62. Riviere S., Birlouez-Aragon I., Nourhashémi F., Vellas B., Low plasma vitamin C in Alzheimer patients despite an adequate diet. International Journal of Geriatric Psychiatry 1998 13 11 749 754 (Pubitemid 28542706)
63. von Arnim C. A., Herbolsheimer F., Nikolaus T., Dietary antioxidants and dementia in a population-based case-control study among older people in South Germany. Journal of Alzheimer's Disease 2012 31 4 717 724
64. Schippling S., Kontush A., Arlt S., Buhmann C., Stürenburg H.-J., Mann U., Müller-Thomsen T., Beisiegel U., Increased lipoprotein oxidation in Alzheimer's disease. Free Radical Biology and Medicine 2000 28 3 351 360 2-s2.0-0033951991 10.1016/S0891-5849(99)00247-6 (Pubitemid 30110650)
65. Cherubini A., Ruggiero C., Polidori M. C., Mecocci P., Potential markers of oxidative stress in stroke. Free Radical Biology and Medicine 2005 39 7 841 852 2-s2.0-29144435788 10.1016/j.freeradbiomed.2005.06.025
66. Tabet N., Mantle D., Walker Z., Orrell M., Vitamins, trace elements, and antioxidant status in dementia disorders. International Psychogeriatrics 2001 13 3 265 275 2-s2.0-0035180964 10.1017/S1041610201007669 (Pubitemid 33101666)
67. Snaedal J., Kristinsson J., Gunnarsdóttir S., Ó lafsdóttir Á., Baldvinsson M., Jóhannesson T., Copper, ceruloplasmin and superoxide dismutase in patients with Alzheimer's disease. A case-control study. Dementia and Geriatric Cognitive Disorders 1998 9 5 239 242 2-s2.0-0031847561 10.1159/000017067 (Pubitemid 28377223)
68. Kharrazi H., Vaisi-Raygani A., Rahimi Z., Tavilani H., Aminian M., Pourmotabbed T., Association between enzymatic and non-enzymatic antioxidant defense mechanism with apolipoprotein E genotypes in Alzheimer disease. Clinical Biochemistry 2008 41 12 932 936 2-s2.0-47049127899 10.1016/j.clinbiochem.2008. 05.001
69. Perrin R., Briancon S., Jeandel C., Artur Y., Minn A., Penin F., Siest G., Blood activity of Cu/Zn superoxide dismutase, glutathione peroxidase and catalase in Alzheimer's disease: a case-control study. Gerontology 1990 36 5-6 306 313 2-s2.0-0025670273
70. Rossi L., Squitti R., Pasqualetti P., Marchese E., Cassetta E., Forastiere E., Rotilio G., Rossini P. M., Finazzi-Agró A., Red blood cell copper, zinc superoxide dismutase activity is higher in Alzheimer's disease and is decreased by D-penicillamine. Neuroscience Letters 2002 329 2 137 140 2-s2.0-0037199654 10.1016/S0304-3940(02)00599-2 (Pubitemid 34880058)
71. De Leo M. E., Borrello S., Passantino M., Palazzotti B., Mordente A., Daniele A., Filippini V., Galeotti T., Masullo C., Oxidative stress and overexpression of manganese superoxide dismutase in patients with Alzheimer's disease. Neuroscience Letters 1998 250 3 173 176 2-s2.0-0032504035 10.1016/S0304-3940(98)00469-8 (Pubitemid 28355805)
72. Bowes M. P., Zivin J. A., Thomas G. R., Thibodeaux H., Fagan S. C., Acute hypertension, but not thrombolysis, increases the incidence and severity of hemorrhagic transformation following experimental stroke in rabbits. Experimental Neurology 1996 141 1 40 46 2-s2.0-0030249686 10.1006/exnr.1996.0137 (Pubitemid 26317180)
73. Baldeiras I., Santana I., Proença M. T., Garrucho M. H., Pascoal R., Rodrigues A., Duro D., Oliveira C. R., Peripheral oxidative damage in mild cognitive impairment and mild Alzheimer's disease. Journal of Alzheimer's Disease 2008 15 1 117 128 2-s2.0-52449117220
74. Nunomura A., Tamaoki T., Motohashi N., Nakamura M., McKeel D. W., Tabaton M., Lee H.-G., Smith M. A., Perry G., Zhu X., The earliest stage of cognitive impairment in transition from normal aging to alzheimer disease is marked by prominent RNA oxidation in vulnerable neurons. Journal of Neuropathology and Experimental Neurology 2012 71 3 233 241 2-s2.0-84857540524 10.1097/NEN. 0b013e318248e614
75. Paraskevas G. P., Kapaki E., Libitaki G., Zournas C., Segditsa I., Papageorgiou C., Ascorbate in healthy subjects, amyotrophic lateral sclerosis and Alzheimer's disease. Acta Neurologica Scandinavica 1997 96 2 88 90 2-s2.0-0030796072 (Pubitemid 27343575)
76. Vural H., Demirin H., Kara Y., Eren I., Delibas N., Alterations of plasma magnesium, copper, zinc, iron and selenium concentrations and some related erythrocyte antioxidant enzyme activities in patients with Alzheimer's disease. Journal of Trace Elements in Medicine & Biology 2010 24 3 169 173